Sequential use of second ‐generation tyrosine kinase inhibitors following imatinib therapy in pediatric chronic myeloid leukemia: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group

Pediatric Blood&Cancer, EarlyView.

Source: Pediatric Blood and Cancer - August 7, 2018 Category: Cancer & Oncology Authors: HidemitsuKurosawa , AkihikoTanizawa , HidekiMuramatsu , ChikakoTono , AkihiroWatanabe , HarukoShima , MasakiIto , YukiYuza , KazukoHamamoto , NorikoHotta , MasahikoOkada , Akiko MoriyaSaito , AtsushiManabe , ShukiMizutani , Source Type: research